isradipine has been researched along with Channelopathies in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Channelopathies: A variety of neuromuscular conditions resulting from MUTATIONS in ION CHANNELS manifesting as episodes of EPILEPSY; HEADACHE DISORDERS; and DYSKINESIAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Török, F | 1 |
| Tezcan, K | 1 |
| Filippini, L | 1 |
| Fernández-Quintero, ML | 1 |
| Zanetti, L | 1 |
| Liedl, KR | 1 |
| Drexel, RS | 1 |
| Striessnig, J | 1 |
| Ortner, NJ | 1 |
1 other study available for isradipine and Channelopathies
| Article | Year |
|---|---|
Germline de novo variant F747S extends the phenotypic spectrum of CACNA1D Ca2+ channelopathies.
Topics: Calcium; Calcium Channels, L-Type; Channelopathies; Germ Cells; Germ-Line Mutation; Humans; Isradipi | 2023 |